Homie Razavi is the founder and managing director at the Center for Disease Analysis Foundation (CDAF), an organization working to accelerate hepatitis B and C elimination through development of verified epidemiological data, disease burden and economic impact modeling, intervention strategies, and access to affordable diagnostics and treatments. Since 2008, Homie has led a team of epidemiologists and modellers to quantify epidemiology of hepatitis C virus (HCV) and forecast the future impact of HCV disease burden. They have analyzed HCV disease burden in over seventy countries and have helped countries develop national strategies. CDAF has been responsible for the development of a number of mathematical models currently used by countries to develop intervention strategies for HCV and HBV: HCV disease progression HCV transmission HCV economic impact HBV vertical transmission & economic impact HBV disease progression/treatment & economic impact In addition, CDAF has developed the Polaris Observatory, which collects and reports HCV, HBV and HDV epidemiology, disease burden and treatment rate annually. He has a broad background, which includes basic research, commercial development, portfolio management, and decision analysis. He is also a fellow in the Society of Decision Professionals.